Federal Register / Vol. 72, No. 14 / Tuesday, January 23, 2007 / Notices 2907 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on August 21, 2006, 

Cedarburg Pharmaceuticals, Inc., 870 

Badger Circle, Grafton, Wisconsin 

53024, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in schedule 

I and II: 

Drug Schedule 

Tetrahydrocannabinols (7370) ..... I 

Dihydromorphine (9145) ............... I 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Hydrocodone (9193) ..................... II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................ II 

Remifentanil (9739) ...................... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such substances 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative/ODL; or 

any being sent via express mail should 

be sent to DEA Headquarters, Attention: 

DEA Federal Register Representative/ 

ODL, 2401 Jefferson-Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than March 26, 2007. 

Dated: January 16, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–850 Filed 1–22–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on September 20, 

2006, Organix Inc., 240 Salem Street, 

Woburn, Massachusetts 01801, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Tetrahydrocannabinols (7370), a basic 

class of controlled substance listed in 

schedule II. 

The company plans on manufacturing 

this controlled substance for sale to its 

customers. These customers will sell the 

drug in small quantities for research 

purposes or as drug standards for 

forensic laboratories. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative/ODL; or 

any being sent via express mail should 

be sent to DEA Headquarters, Attention: 

DEA Federal Register Representative/ 

ODL, 2401 Jefferson-Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than March 26, 2007. 

Dated: January 16, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–851 Filed 1–22–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

National Institute of Corrections 

Advisory Board Meeting 

Time and Date: 8 a.m. to 4:30 p.m. on 

Monday, February 26, 2007. 8 a.m. to 

4:30 p.m. on Tuesday, February 27, 

2007. 

Place: American Correctional 

Association, 206 North Washington 

Street, Suite 200, Alexandria, Virginia 

22314, 1 (800) 222–5646. 

Status: Open. 

Matters to be Considered: Reports; 

Faith Based; Mental health; Prison Rape 

Elimination Act (PREA) Update; Agency 

reports; Quarterly Report by Office of 

Justice Programs. 

Contact Person for More Information: 

Larry Solomon, Deputy Director, 202–

307–3106, ext. 44254. 

Morris L. Thigpen, 

Director. 

[FR Doc. 07–255 Filed 1–22–07; 8:45 am] 

BILLING CODE 4410–30–M 

NUCLEAR REGULATORY 

COMMISSION 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

AGENCY: U.S. Nuclear Regulatory 

Commission (NRC). 

ACTION: Notice of pending NRC action to 

submit an information collection 

request to OMB and solicitation of 

public comment. 

SUMMARY: The NRC is preparing a 

submittal to OMB for review of 

continued approval of information 

collections under the provisions of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. Chapter 35). 

Information Pertaining to the 

Requirement To Be Submitted 

1. The title of the information 

collection: NRC Form 314, Certificate of 

Disposition of Materials. 

2. Current OMB approval numbers: 

3150–0028. 

3. How often the collection is 

required: The form is submitted once, 

when a licensee terminates its license. 

4. Who is required or asked to report: 

Persons holding an NRC license for the 

possession and use of radioactive 

byproduct, source, or special nuclear 

material who are ceasing licensed 

activities and terminating the license. 

5. The estimated number of annual 

respondents: 171. 

6. The number of hours needed 

annually to complete the requirement or 

request: 85.5. 

7. Abstract: NRC Form 314 furnishes 

information to NRC regarding transfer or 

other disposition of radioactive material 

by licensees who wish to terminate their 

licenses. The information is used by 

NRC as part of the basis for its 

determination that the facility has been 

cleared of radioactive material before 

the facility is released for unrestricted 

use. 

Submit, by March 26, 2007, comments 

that address the following questions: 

1. Is the proposed collection of 

information necessary for the NRC to 

mstockstill on PROD1PC70 with NOTICES